Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy

被引：33

作者：

Helgason, Gudmundur V. ^{[1
]}

Mukhopadhyay, Arunima ^{[1
]}

Karvela, Maria ^{[1
]}

Salomoni, Paolo ^{[2
]}

Calabretta, Bruno ^{[3
]}

Holyoake, Tessa L. ^{[1
]}

机构：

[1] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Paul OGorman Leukaemia Res Ctr, Glasgow G12 0ZD, Lanark, Scotland

[2] UCL, Inst Canc, Samantha Dickson Brain Canc Unit, London WC1E 6BT, England

[3] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA

来源：

CURRENT CANCER DRUG TARGETS | 2013年 / 13卷 / 07期

基金：

英国医学研究理事会;

关键词：

Autophagy; Bcr-Abl; CML; clinical trials; glioblastoma; haemopoietic stem cells; HCQ; ROS; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; KINASE-ACTIVITY; TARGETING AUTOPHAGY; HEMATOPOIETIC PROGENITORS; PRIMARY CML; INHIBITION; IMATINIB; QUIESCENT; MITOCHONDRIA;

D O I：

10.2174/15680096113139990088

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The insensitivity of Chronic Myeloid Leukaemia (CML) stem cells to Tyrosine Kinase Inhibitor (TKI) treatment is now believed to be the main reason for disease persistence experienced in patients. It has been shown that autophagy, an evolutionarily conserved catabolic process that involves degradation of unnecessary or harmful cellular components via lysosomes, is induced following TKI treatment in CML cells. Of clinical importance, autophagy inhibition, using the anti-malarial drug hydroxychloroquine (HCQ), sensitised CML cells, including primitive CML stem cells, to TKI treatment. In this review we discuss the role of autophagy in the maintenance and survival of stem cells in more detail, with a focus on its role in survival of CML stem cells and the possibility to inhibit this pathway as a way to eliminate persistent CML stem cells in vitro and in patients.

引用

页码：724 / 734

页数：11

共 50 条

[1] Targeting survival pathways in chronic myeloid leukaemia stem cells
Sinclair, A.
Latif, A. L.
Holyoake, T. L.
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (08) : 1693 - 1707
[2] CLONAL STRUCTURES OF LEUKAEMIA STEM CELL POPULATIONS IN MYELOID BLAST PHASE CHRONIC MYELOID LEUKAEMIA
Karamitros, D.
Morrison, H.
Kinstrie, R.
Goardon, N.
Clark, R. E.
Copland, M.
Vyas, P.
HAEMATOLOGICA, 2016, 101 : 234 - 235
[3] Sign of the Zodiac as a predictor of survival for recipients of an allogeneic stem cell transplant for chronic myeloid leukaemia
Szydlo, R.
Gabriel, I.
Olavarria, E.
Apperley, J.
BONE MARROW TRANSPLANTATION, 2008, 41 : S348 - S348
[4] Development of donor cell derived acute myeloid leukaemia after stem cell transplantation for chronic myeloid leukaemia
Pieroni, F
Oliveira, FM
Moraes, D
Straccieri, ABPL
Rodrigues, MC
Panepucci, RA
Voltarelli, JC
Simoes, BP
Falcao, RP
BONE MARROW TRANSPLANTATION, 2006, 37 : S219 - S220
[5] Chronic myeloid leukaemia: stem cell derived but progenitor cell driven
Marley, SB
Gordon, MY
CLINICAL SCIENCE, 2005, 109 (01) : 13 - 25
[6] Current role of stem cell transplantation in chronic myeloid leukaemia
Gratwohl, Alois
Heim, Dominik
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) : 431 - 443
[7] Getting to the stem of chronic myeloid leukaemia
Savona, Michael
Talpaz, Moshe
NATURE REVIEWS CANCER, 2008, 8 (05) : 341 - 350
[8] Getting to the stem of chronic myeloid leukaemia
Michael Savona
Moshe Talpaz
Nature Reviews Cancer, 2008, 8 : 341 - 350
[9] Haematopoietic stem cell transplantation for treatment of chronic myeloid leukaemia in childhood
Suttorp, M
Klöpper, K
Hasenkamp, J
BONE MARROW TRANSPLANTATION, 2001, 27 : S143 - S143
[10] Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukaemia
Perz, JB
Sanz, J
Ghorashian, S
Chaidos, A
Kaeda, J
Szydlo, RM
Marin, DC
Olavarria, E
Apperley, JF
BONE MARROW TRANSPLANTATION, 2006, 37 : S227 - S227

← 1 2 3 4 5 →